Status:
UNKNOWN
The Benefit of Hippotherapy in Stroke Patients
Lead Sponsor:
Centre Hospitalier Universitaire de Liege
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to explore the interest of hippotherapy in the management of patients with stroke in the sequelae phase by evaluating the psychological and physical well-being. It is a controlled and ...
Eligibility Criteria
Inclusion
- patients who have suffered a stroke and who are in a sequelae phase (after hospitalization or discharge from the rehabilitation center)
- patients who have sufficient trunk balance to hold on to the horse
- patients who have the consent of their doctor
- patients who indicated their agreement to participate in the study by signing the consent form
Exclusion
- pressure sore at the seat level
- other lesion or neurological history
- severe cognitive deficits affecting the understanding
- do not understand French language
- allergy to horses
- weigh more than 100 kg
- acute pain syndrome
- epilepsy
- patient has benefited from hippotherapy sessions during the last 6 months
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05345886
Start Date
May 1 2022
End Date
January 1 2025
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CNRF
Tinlot, Liège, Belgium, 4557